Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 6/20 | 0.51 |
| ▸ | CA2 | P00918 | 6/20 | 0.51 |
| ▸ | CA9 | Q16790 | 6/20 | 0.51 |
| ▸ | CA12 | O43570 | 3/20 | 0.51 |
| ▸ | PYGB | P11216 | 7/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6683938 | 0.98 | CA1 (0.54) | CA1CA2CA9CA12PYGB | |
| SCHEMBL6683943 | 0.98 | CA1 (0.54) | CA1CA2CA9CA12PYGB | |
| SCHEMBL31207057 | 0.84 | PYGB (0.51) | CA1CA2CA9CA12PYGB | |
| SCHEMBL14940452 | 0.82 | PYGB (0.54) | CA1CA2CA9CA12PYGB | |
| SCHEMBL16256436 | 0.82 | PYGB (0.54) | CA1CA2CA9CA12PYGB | |
| SCHEMBL28589455 | 0.82 | PYGB (0.54) | CA1CA2CA9CA12PYGB | |
| SCHEMBL1208980 | 0.78 | PYGB (0.62) | CA1CA2CA9CA12PYGB | |
| SCHEMBL22195972 | 0.78 | PYGB (0.62) | CA1CA2CA9CA12PYGB | |
| SCHEMBL1208976 | 0.78 | PYGB (0.62) | CA1CA2CA9CA12PYGB | |
| SCHEMBL10939188 | 0.76 | PYGB (0.65) | CA1CA2CA9CA12PYGB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119875972-A | Methods and compositions for preventing microbial infection | 比奥普来克斯有限公司 | 2025-04-25 | — | — | CN | claimed |
| CN-119875972-A | Methods and compositions for preventing microbial infection | 比奥普来克斯有限公司 | 2025-04-25 | — | — | CN | disclosed |
| CN-111918960-B | Methods and compositions for preventing microbial infection | 比奥普来克斯有限公司 | 2025-01-28 | — | — | CN | disclosed |
| CN-118974259-A | Microorganism producing purine nucleotide and method for producing purine nucleotide using the same | CJ第一制糖株式会社 | 2024-11-15 | — | — | CN | disclosed |
| US-20240350027-A1 | Methods and Apparatus for Benchtop Metabolite Profiling in Situ | VIBO HEALTH INC (US) | 2024-10-24 | — | — | US | disclosed |
| CN-118765327-A | Microorganism producing purine nucleotide and method for producing purine nucleotide using the same | CJ第一制糖株式会社 | 2024-10-11 | — | — | CN | disclosed |
| CN-118742646-A | Microorganism producing purine nucleotide and method for producing purine nucleotide using the same | CJ第一制糖株式会社 | 2024-10-01 | — | — | CN | disclosed |
| CN-116916944-A | Vaccine, therapeutic agent and RNA delivery platform based on immunostimulatory bacteria | 阿克蒂姆治疗有限公司 | 2023-10-20 | — | — | CN | disclosed |
| CN-116249779-A | Immunostimulatory bacteria delivery platform and use thereof for delivering therapeutic products | 阿克蒂姆治疗有限公司 | 2023-06-09 | — | — | CN | disclosed |